Dual‐Responsive Nanogels with Cascaded Gentamicin Release and Lysosomal Escape to Combat Intracellular Small Colony Variants for Peritonitis and Sepsis Therapies
Advanced Healthcare Materials · 2024
DOI: 10.1002/adhm.202303671 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2024. Verfasst von Shuang Xie und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Life Science and Engineering, Key Laboratory of Advanced Technologies of Materials, Ministry of Education, Southwest Jiaotong University, C…. Hauptthemen laut MEDLINE: Peritonitis, Gentamicins, Sepsis, Lysosomes. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 54 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Key Research and Development Program of Sichuan Province.
Themen: Sepsis
Abstract (Originalsprache)
Intracellular bacteria are the major cause of serious infections including sepsis and peritonitis, but face great challenges in fighting against the stubborn intracellular small colony variants (SCVs). Herein, the authors have developed nanogels (NGs) to destroy both planktonic bacteria and SCVs and eliminate excessive inflammations for peritonitis and sepsis therapies. Free gentamicin (GEN) and hydroxyapatite nanoparticles (NPs) with GEN loading and mannose grafts (mHA G ) are inoculated into ε‐polylysine NGs to obtain NG@G1‐mHA G2 through crosslinking with phenylboronic acid and tannic acid. The H 2 O 2 consumption after reaction with phenylboronic esters and the elimination of free radicals by tannic acid alleviates the escalated inflammatory status to promote sepsis therapy. After mannose‐mediated uptake into macrophages, the acid‐triggered degradation of mHA G NPs generates Ca 2+ to destabilize lysosomes and the efficient lysosomal escape leads to reversion of hypometabolic SCVs into normal phenotype and their sensitivity to GEN. In a peritonitis mouse model, NG@G1‐mHA G2 treatment provides strong and persistent bactericidal effects against both extracellular bacteria and intracellular SCVs and extends survival of peritonitis mice without apparent hepatomegaly, splenomegaly, pulmonary edema, and inflammatory cell infiltration. Thus, this study demonstrates a concise and versatile strategy to eliminate SCVs and relieve inflammatory storms for peritonitis and sepsis therapies without infection recurrence.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Life Science and Engineering, Key Laboratory of Advanced Technologies of Materials, Ministry of Education, Southwest Jiaotong University, Chengdu, 610031, P. R. China.
- Institute of Biomedical Engineering, College of Medicine, Southwest Jiaotong University, Chengdu, 610031, P. R. China.
- School of Materials Science and Engineering, Southwest Jiaotong University, Chengdu, 610031, P. R. China.
ORCID-Profile: Xiaohong Li
Förderung
- National Natural Science Foundation of China
- Key Research and Development Program of Sichuan Province
Zitieren
APA
Xie, S., Li, Y., Cao, W., Peng, J., Huang, K., Meng, J., & Li, X. (2024). Dual‐Responsive Nanogels with Cascaded Gentamicin Release and Lysosomal Escape to Combat Intracellular Small Colony Variants for Peritonitis and Sepsis Therapies. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202303671
Vancouver
Xie S, Li Y, Cao W, Peng J, Huang K, Meng J, et al. Dual‐Responsive Nanogels with Cascaded Gentamicin Release and Lysosomal Escape to Combat Intracellular Small Colony Variants for Peritonitis and Sepsis Therapies. Advanced Healthcare Materials. 2024. doi:10.1002/adhm.202303671
BibTeX
@article{Xie2024,
author = {Xie, Shuang and Li, Yu and Cao, Wenxiong and Peng, Jiawen and Huang, Kun and Meng, Jie and Li, Xiaohong},
title = {Dual‐Responsive Nanogels with Cascaded Gentamicin Release and Lysosomal Escape to Combat Intracellular Small Colony Variants for Peritonitis and Sepsis Therapies},
journal = {Advanced Healthcare Materials},
year = {2024},
doi = {10.1002/adhm.202303671}
}
EUVIMED